Every growing company will, at some point, need to convince people to invest or continue investing in the business.

But what motivates investors in their decision-making process? And does addressing potential objections upfront impact their decisions?

To find out, Dr. Carmen Simon, cognitive neuroscientist and Chief Science Officer at Corporate Visions and B2B DecisionsLabs, led a neuroscience study to see how investors and analysts react to risk-related information in a first-call presentation.

Get this research brief to find out:

  • How including potential objections in a slide impacts attention, satisfaction with the investment opportunity, and the motivation to act.
  • How introducing risk-related information impacts how investors remember important points from the presentation.
  • Whether you should share risk-related information during a first-call investor presentation.